Skip to main content
SpringerLink
Log in

Simvastatin under scrutiny in hyperlipidaemia

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Results from a multinational study have shown that Warner-Lambert’s simvastatin increases HDL-cholesterol and apolipoprotein A-I levels to a significantly greater extent than Merck’s atorvastatin in patients with hypercholesterolaemia. The study was one of several presented at the 48th Annual Scientific Session of the American College of Cardiology [ New Orleans, US; March 1999 ] to investigate the efficacy of simvastatin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Tracey Earl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Earl, T. Simvastatin under scrutiny in hyperlipidaemia. Inpharma Wkly. 1183, 15–16 (1999). https://doi.org/10.2165/00128413-199911830-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199911830-00026

Keywords

Search

Navigation